Ascendis Pharma A/S - ADR

NASDAQ:ASND   3:59:40 PM EDT
162.35
+3.07 (+1.93%)
Earnings Announcements

Ascendis Pharma A/S Reports Q3 Loss Per Share Eur 2.31

Published: 11/11/2020 21:42 GMT
Ascendis Pharma A/S (ASND) - Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share EUR 2.31.
Q3 Revenue EUR 2.8 Million Versus EUR 2.2 Million.
Revenue is expected to be $1.96 Million
Adjusted EPS is expected to be -$1.87

Next Quarter Revenue Guidance is expected to be $1.57 Million
Next Quarter EPS Guidance is expected to be -$2.07

More details on our Analysts Page.